BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16466309)

  • 1. Olanzapine/fluoxetine combination for bipolar depression.
    Shelton RC
    Expert Rev Neurother; 2006 Jan; 6(1):33-9. PubMed ID: 16466309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of bipolar depression: making sensible decisions.
    Citrome L
    CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
    Calabrese JR; Elhaj O; Gajwani P; Gao K
    J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spotlight on olanzapine/fluoxetine in acute bipolar depression.
    Deeks ED; Keating GM
    CNS Drugs; 2008; 22(9):793-5. PubMed ID: 18698877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine-fluoxetine combination for the treatment of bipolar depression.
    Citrome L
    Expert Opin Pharmacother; 2011 Dec; 12(17):2751-8. PubMed ID: 22035291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
    Taylor DM; Cornelius V; Smith L; Young AH
    Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options for bipolar depression.
    Bowden CL
    J Clin Psychiatry; 2005; 66 Suppl 1():3-6. PubMed ID: 15693745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of FDA-approved treatment options in bipolar depression.
    McIntyre RS; Cha DS; Kim RD; Mansur RB
    CNS Spectr; 2013 Dec; 18 Suppl 1():4-20; quiz 21. PubMed ID: 24237641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of treatments for bipolar depression.
    Vázquez GH; Holtzman JN; Tondo L; Baldessarini RJ
    J Affect Disord; 2015 Sep; 183():258-62. PubMed ID: 26042634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine/fluoxetine: a review of its use in the treatment of acute bipolar depression.
    Deeks ED; Keating GM
    Drugs; 2008; 68(8):1115-37. PubMed ID: 18484802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing benefits and harms of treatments for acute bipolar depression.
    Ketter TA; Miller S; Dell'Osso B; Calabrese JR; Frye MA; Citrome L
    J Affect Disord; 2014 Dec; 169 Suppl 1():S24-33. PubMed ID: 25533911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of bipolar depression: an update.
    Fountoulakis KN; Grunze H; Panagiotidis P; Kaprinis G
    J Affect Disord; 2008 Jul; 109(1-2):21-34. PubMed ID: 18037498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of olanzapine and fluoxetine in mood disorders.
    Shelton RC
    Expert Opin Pharmacother; 2003 Jul; 4(7):1175-83. PubMed ID: 12831342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
    Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spotlight on olanzapine in bipolar I disorder.
    McCormack PL; Wiseman LR
    CNS Drugs; 2005; 19(6):553-5. PubMed ID: 15963003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolar depression: a new role for atypical antipsychotics?
    Keck PE
    Bipolar Disord; 2005; 7 Suppl 4():34-40. PubMed ID: 15948765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine: a review of its use in the management of bipolar I disorder.
    McCormack PL; Wiseman LR
    Drugs; 2004; 64(23):2709-26. PubMed ID: 15537371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.
    Yatham LN; Kennedy SH; O'Donovan C; Parikh SV; MacQueen G; McIntyre RS; Sharma V; Beaulieu S;
    Bipolar Disord; 2006 Dec; 8(6):721-39. PubMed ID: 17156158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.